Small molecule Pharmaceuticals & Agrochemicals
Biopharmaceuticals
(currently AGC Wakasa Chemicals)
(currently Milan site)
-
Developed Highly Efficient and Rapid Protein Production Technology "ASPEX" using fission yeast
-
Obtained marketing approval for tafluprost, an anti-glaucoma drug substance developed jointly with Santen Pharmaceutical
-
Established a new plant, Kaminaka Plant, in the Wakasa Techno-Valley (AGC Wakasa Chemicals)
-
Acquired biopharmaceutical CDMO with sites in Europe and U.S. (currently Seattle & Copenhagen sites)
-
Acquired drug substance manufacturing plant in Spain (currently AGC Pharma Chemicals Europe)
-
Acquired Italian cell & gene therapy CDMO (currently Milan site)
-
Acquired U.S. biopharmaceutical drug substance manufacturing plant (currently Boulder site)